A novel glycogen synthase kinase-3 inhibitor 2-methyl-5-(3-{4-[(s)-methylsulfinyl]phenyl}-1-benzofuran-5-yl)-1,3,4-oxadiazole (mmbo) decreased tau phosphorylation and ameliorated cognitive deficits in a transgenic model of Alzheimer's disease

详细信息    查看全文

• 作者：Tomohiro Onishi¹ ; Hiroki Iwashita¹ ; Yumiko Uno² ; Jun Kunitomo² ; Morihisa Saitoh² ; Eiji Kimura² ; Hisashi Fujita² ; Noriko Uchiyama² ; Masakuni Kori² ; Masayuki Takizawa²
• 刊名：Alzheimer's Dementia
• 出版年：2011
• 出版时间：July 2011
• 年：2011
• 卷：7
• 期：4, Supplement 1
• 页码：S482
• 全文大小：54 K

文摘